Clinical Trials Browser

Phase 3 × Unknown × nilotinib × Clear all

NCT03942094 2022-03-16

Nilotinib for First-line Newly Diagnosed CML-CP Patients

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT01400074 2014-01-13

RE-NICE

Phase 3 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive